Alembic Pharmaceuticals gets FDA approval for Formoterol Fumarate Inhalation Solution

Alembic Pharmaceuticals gets FDA approval for Formoterol Fumarate Inhalation Solution

Alembic Pharmaceuticals said that it has secured final approval from the US Food and Drug Administration (FDA) for Formoterol Fumarate Inhalation Solution, 20 mcg/2 ml per Unit-Dose Vial. The approved Abbreviated New Drug Application (ANDA) is therapeutically equivalent to Perforomist Inhalation Solution, 20 mcg/2 ml per Unit-Dose Vial, the reference listed drug product (RlD) owned […]